https://plx5622.com/index.php/....primary-cancer-malig
After matching, the BACD team showed somewhat lower total bilirubin levels in the 3-month followup (0.5 vs. 1.5 mg/dL, p = 0.036) and higher 5-year native liver survival rate (95.2% vs. 57.5%, p = 0.006) compared to the IBA team. SUMMARY BACD demonstrated higher bilirubin clearance and native liver success rates than IBA. LEVELS OF EVIDENCE Treatment Study, Level III. PURPOSE Outcomes and resource application had been examined after implementing a novel complex appendicitis (CA) p
Like
Comment
Share
